Clinical Trial - Sleep Apnea

Patient Benefits

Provide an alternative for those unable or unwilling to use CPAP as over 50% of OSA patients are non-compliant with CPAP use.

Improve patient outcomes because OSA sufferers have a 30% higher risk of heart attack or premature death. Stroke, diabetes, car accidents and depression are other serious OSA risks.

How to refer my patients?

To refer patients, please copy the below link (by clicking on the copy link button) and provide it to your patients.
http://rnsights.com/imthera2/patient_register.html (Copy Link)

The patient will be able to register to learn more about the clinical study and provide your name as the referring HCP.

If you intend to refer a patient, click here so we can add you to the referring HCP list to inform you of any updates to this study.

Study Overview:

What we do?

The study is intended to demonstrate the safety and efficacy of Targeted Hypoglossal Neurostimulation (THN) for those that are unable or unwilling to use CPAP. The THN Sleep Therapy™ System is designed to reduce or eliminate sleep apnea episodes. Essentially a pacemaker for the tongue, it provides mild electrical stimulation to the hypoglossal nerve through a surgically implanted medical device.

Key patient inclusion criteria:

Moderate-to-severe Obstructive Sleep Apnea
AHI between 20 and 65
No more than 10% central apneas
BMI less than 35
Unwilling or unable to use CPAP
Willing to undergo surgery
Have PSG (Polysomnograph) results

Please copy the link (by clicking on the link) and provide it to your patients (Copy Link)
so the patient can register to learn more about the study.

Resources for Healthcare Practitioners Referring Patients

Questions from HCPs

If an HCP has any questions about the referral process or the study, please click on the red box.

Questions

Referral Letter to Patients

See attached sample letter to send to patients.

Site locations

There are study sites throughout the United States. To find a specific site near you, please click on the box.

View Sites

Sleep Therapy brochure

If you suffer from obstructive sleep apnea (OSA), and have not received lasting benefit from CPAP or other treatments, you may be a candidate for a new clinical research study.

Sleep Therapy FAQ

How long will the implant last?
The THN Sleep TherapyTM system is designed to last up to 15-years before battery replacement is required.

Pre-Screening Questionnaire

The pre-screening questionnaire is the first step toward seeing if you qualify for the THN Sleep Therapy Study. The questionnaire will help determine if you meet some of the main criteria for the study.

Obstructive Sleep Apnea

Obstructive Sleep Apnea (OSA) is a serious medical condition that occurs when soft-tissue blocks the airway during sleep, depriving the brain of oxygen and causing sufferers to awake repeatedly throughout the night.

OSA by the Numbers

Obstructive Sleep Apnea afflicts 1 in every 5 Americans. What other problems arise for OSA patients?